Chondrogenesis of human adipose-derived mesenchymal stromal cells on the [devitalized costal cartilage matrix/poly(vinyl alcohol)/fibrin] hybrid scaffolds by Setayeshmehr, Mohsen et al.
 
 
 
Chondrogenesis of human adipose-derived
mesenchymal stromal cells on the [devitalized costal
cartilage matrix/poly(vinyl alcohol)/fibrin] hybrid
scaffolds
Citation for published version (APA):
Setayeshmehr, M., Esfandiari, E., Hashemibeni, B., Tavakoli, A. H., Rafienia, M., Samadikuchaksaraei,
A., Moroni, L., & Joghataei, M. T. (2019). Chondrogenesis of human adipose-derived mesenchymal
stromal cells on the [devitalized costal cartilage matrix/poly(vinyl alcohol)/fibrin] hybrid scaffolds. European
Polymer Journal, 118, 528-541. https://doi.org/10.1016/j.eurpolymj.2019.04.044
Document status and date:
Published: 01/09/2019
DOI:
10.1016/j.eurpolymj.2019.04.044
Document Version:
Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 05 Jan. 2021
Contents lists available at ScienceDirect
European Polymer Journal
journal homepage: www.elsevier.com/locate/europolj
Chondrogenesis of human adipose-derived mesenchymal stromal cells on
the [devitalized costal cartilage matrix/poly(vinyl alcohol)/fibrin] hybrid
scaffolds
Mohsen Setayeshmehra,b, Ebrahim Esfandiaric, Batool Hashemibenic, Amir Hossein Tavakolid,
Mohammad Rafieniae, Ali Samadikuchaksaraeia,f, Lorenzo Moronib,
Mohammad Taghi Joghataeia,f,⁎
a Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
bMERLN Institute for Technology Inspired Regenerative Medicine, Complex Tissue Regeneration, Maastricht University, Maastricht, the Netherlands
c Department of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
d Iranian Tissue Bank Research Center, Tehran University of Medical Sciences, Tehran, Iran
e Biomaterials Nanotechnology and Tissue Engineering Group, Department of Advanced Medical Technology, Isfahan University of Medical Sciences, Isfahan, Iran
f Cellular and Molecular Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
A R T I C L E I N F O
Keywords:
Devitalized costal cartilage matrix
Poly vinyl alcohol
Genipin
Hybrid scaffold
Cartilage tissue engineering
A B S T R A C T
Porous scaffolds derived from native cartilage matrix along with autologous cells could be an effective tool for
cartilage tissue engineering (CTE). Recently, it was shown that scaffolds based on cartilage extra cellular matrix
(ECM) can induce chondrogenesis of human adipose-derived mesenchymal stromal cells (ASCs) without using
exogenous growth factors. However, lack of mechanical properties, rapid biodegradation, and contraction of
these scaffolds in culture limit further applications. The present study investigated the fabrication of novel
scaffolds based on devitalized costal cartilage matrix (DCM) and poly vinyl alcohol (PVA), using genipin as a
natural crosslinker. For this purpose, PVA was modified to expose amine groups (PVA-A), which crosslinked with
DCM powder via the lowest genipin percentage of 0.04% (wt/wt). The crosslinked scaffolds were characterized
by different techniques including porosity percentage, pore size, mechanical properties, crosslinking density, and
swelling. ASCs were seeded on the scaffolds using fibrin hydrogel. Gene expression measurements, biochemical
assays and histological staining confirmed that ASC-seeded constructs cultured in the chondrogenic medium can
express cartilage-specific genes and synthesize cartilage-related macromolecules. In the presence of TGF-β3 the
constructs exhibited significant expression of these markers compared to the control medium. These findings
suggest that [genipin-crosslinked DCM-PVA-A/ fibrin] can be considered as an appealing hybrid scaffold for CTE
applications.
1. Introduction
Articular cartilage has a limited self-repair capacity because of no
vascularity and absence of progenitor cells. Traumatic damages and
osteoarthritis are among the main reasons of articular cartilage de-
generation [1–3]. The common clinical actions for healing of cartilage
defects consist of microfracture, autologous chondrocyte transplanta-
tion, and allograft implants. However, none of these treatments
achieves complete renewal of functional cartilage. Therefore, tissue
engineering (TE) has been employed to promote cartilage regeneration
using natural or synthetic scaffolds, stem cells, and growth factors
[4,5].
Polymeric materials to design hybrid and composite scaffolds in
cartilage tissue engineering more frequently consist of poly(DL-lactic-
co-glycolic acid) (PLGA), poly(L-lactic acid) (PLA), poly(ε-capro-
lactone) (PCL), poly ethylene glycol (PEG), poly vinyl alcohol (PVA),
and methacrylamide modification (MA) thereof [6]. Synthetic scaffolds
are known to display adequate mechanical properties to match those of
cartilage tissues, but their lack of appropriate biological cues reflect a
main drawback [7]. PVA is one of the most studied polymers in
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biomedical applications, because of its great biocompatibility in com-
bination with a variety of appropriate biophysical properties. PVA has
appropriate mechanical properties, swelling capacity, ability to fabri-
cate a pore construction via chemical modifications and crosslinking
opportunities [8]. The repeated freeze-thawing cycles, chemical cross-
linking, dehydrothermal process and ultra violet (UV) irradiation are
the mostly used crosslinking methods [9,10]. Despite these mentioned
advantages, PVA has no appropriate integration ability with the sur-
rounding natural tissue due to its lack of cell attachment binding sites
[11]. However, different modifications have been shown on PVA hy-
drogels to promote biological properties such as cell proliferation,
viability, migration, cell attachment and integration with the sur-
rounding tissue [10].
Scaffolds derived from extracellular matrix (ECM) components in-
duce cell attachment, proliferation and differentiation, but generally
don’t have proper mechanical properties and load bearing capacity
[12]. The applications of cartilage ECM derivatives is growing in or-
thopedic medicine due to their chondroinduction ability [13]. The
ability of cartilage ECM derivatives to preserve growth factors (GF)s is
the key benefit of using this material as a scaffold [14]. Some studies
have shown the ability of cartilage extract [15] and cartilage ECM to
induce chondrogenesis in vivo and in vitro [16]. The native tissue is
considered as one of the major types of ECM derivatives [17–19]. While
autologous cartilage is a proper alternative for reconstructive proce-
dures, challenges include donor site morbidity, quality, and avail-
ability. Alternatively, allograft costal cartilage can be considered as a
proper cartilage source in these trials. Costal cartilage specimens are
usually sterilized via gamma (γ) irradiation to reduce the risk of in-
fection transmission from the donor. Several clinical trials supported
the successful use of irradiated allogeneic costal cartilage [20–23].
Decellularization and devitalization can be used to remove all cellular
components or to disrupt cells within the tissue without eliminating
them, respectively. Native cartilage is composed of a dense ECM that is
a challenge to completely decellularize. This limits cell infiltration into
the decellularized matrix [1,12,18]. In one devitalization method, the
tissue is grounded into particles using a freezer-mill and then cellular
components are inactivated by heating without removing them [24].
Freeze-thaw cycles and sonication also have been used for devitaliza-
tion of cartilage [25]. Another technique consists of homogenization
and tissue retrieval, followed by lyophilization of frozen particles [26].
To improve mechanical properties, ECM derived biomaterials can
be mixed with synthetic biomaterials [27,28], or crosslinked via phy-
sical methods including irradiation [29], dehydrothermal (DHT) treat-
ment [30], and chemical crosslinkers such as carbodiimide [28] and
genipin [31,32]. Each of these methods can achieve different cross-
linking density and protein denaturation [33,34], which effect scaffold
contraction [28,35], cell infiltration and cell-matrix interactions [36],
mechanical properties [36], and enzymatic degradation [37]. One of
the common methods for crosslinking of proteins such as collagen and
also some polymeric materials such as PVA is DHT treatment [33]. In
these techniques, water molecules in polymer chains are removed by
increasing temperature under reduced pressure. Nonetheless, dena-
turation of biological component such as collagen chains during heating
process, that may induce immunogenicity, considered as a undesirable
action in the DHT treatment [38–40]. UV irradiation has also been
performed to crosslink PVA hydrogel [41] and also ECM based mate-
rials [26] to function as a vitreous implants or scaffolds for biomedical
applications. To fabricate soft hydrogels, physical cross-linking of PVA
has been also obtained by freezing and thawing cycles [10]. Genipin is a
natural crosslinker with cytotoxicity about 10,000 times lower than
glutaraldehyde [42]. Many studies explored the use of genipin in bio-
medical applications such as a crosslinker of TE scaffolds [43], to de-
crease immunogenicity of the scaffolds previous to implantation
[44,45], for its anti-inflammatory properties [46], and for controlled
release of GFs [47]. The crosslinking mechanism of genipin is via
linking it with primary amine groups of hydroxylysine or lysine
residues on the polypeptide or proteoglycan chains, which results in the
dark blue pigments formed in the matrix [48]. Some studies have
confirmed that genipin crosslinked cartilage derived matrix (CDM) can
prevent scaffolds contraction after cell seeding in conjunction with
conservation of the chondrogenic induction capacity [49]. In spite of
these confident benefits, genipin can inform some unwelcome effects on
CDM, as well as decrease in pore size and prevent cell infiltration,
significant release of collagen and GAG macromolecules during cross-
linking [50].
In this study, we present a novel hybrid scaffold based on devita-
lized costal cartilage matrix (DCM) from human ribs and PVA for CTE
applications. Different physical and chemical crosslinking methods
consisting of freeze-thaw cycles, UV irradiation, dehydrothermal
treatment, and genipin were examined to conjugate these two natural
and synthetic biomaterials. In a novel approach, to increase cross-
linking efficiency and reduce crosslinker percentage, PVA was modified
by more reactive amine functional groups. The crosslinked scaffolds
were characterized by different techniques including porosity percen-
tage, pore size, mechanical properties, crosslinking density, and swel-
ling. An ASCs/fibrin suspension was seeded on the scaffolds to increase
cell attachment and chondrogenic potential. The seeded constructs
were cultured in the chondrogenic medium without/with TGF-β3 to
evaluate the chondrogenic potential of the fabricated scaffolds in
comparison with fibrin hydrogel in micro-mass system.
2. Materials and Methods
2.1. Tissue retrieval and devitalization
Costal cartilages were harvested from the thorax of three organ
donor cadavers (Emmam Khomeini hospital, Tehran, Iran) using scal-
pels [51,52]. The Institutional Ethics Committee of Iran University of
Medical Sciences approved informed consent and the study. Cartilage
was minced and then rinsed in 70% ethanol followed by phosphate
buffered saline (PBS), and frozen at −20 °C. Following freezing, the
cartilage was devitalized using freeze-thawing (3 cycles) and lyophi-
lilzing. Then, the tissue was powdered by a freezer-mill, refrozen, and
stored at−20 °C. Cartilage powder was sterilized using γ radiation 25 G
prior using [1,22].
2.2. Scaffolds fabrication
Porous hybrid scaffolds were fabricated by homogenizing different
ratios of DCM powder to the PVA solutions at the final concentration of
0.1 gr dry wt/ml MiliQ water (MH2O) using vortexing [26,49,50].
Briefly, PVA (72,000MW, Merk) was dissolved in MH2O at 90 °C to
prepare 3 different concentrations of PVA solution (3, 5, 7% wt/vol)
and the solutions were sterilized by 0.22 µm filtration. Adequate
amount of DCM was homogenized in each PVA solution for 3 cycles of
10min (min) vortex at 30,000 rpm and shaking overnight to prepare
DCM-PVA slurries in three different ratios (30:70, 50:50, 70:30 DCM to
PVA). Aliquots of homogenized DCM-PVA (250 µl) were placed in si-
licon molds, frozen overnight at −20 °C and for 1 h (hr) at −70 °C, and
consequently lyophilized for 24 hrs. Cylindrical porous scaffolds with
10mm in diameter, 3 mm thick, and a dry weight of 25mg were pre-
pared. The fabricated scaffolds consisted of 3 groups: 1) [non-cross-
linked DCM-PVA (30:70)] (NCDP30), 2) [non-crosslinked DCM-PVA
(50:50)] (NCDP50), and 3) [non-crosslinked DCM-PVA (70:30)]
(NCDP70). Scaffolds were crosslinked by different methods, as below
described. Finally, ultraviolet light (UV) radiation 30min (min) was
used to sterilize all scaffolds before cell culture.
2.3. Crosslinking methods
2.3.1. Dehydrothermal treatment (DHT)
The NCDP30, NCDP50, and NCDP70 scaffolds were placed inside a
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vacuum oven (Vacucell 22, MMM, Germany) under 120 °C heating and
0.05 bar vacuum for 24 hrs. The crosslinking degree of DHT treatment
of the DCM-PVA scaffolds was determined using a solubility test in PBS
[33].
2.3.2. UV treatment
The NCDP30, NCDP50, and NCDP70 scaffolds were placed inside a
UV cabinet (400W, 265 nm, Iran) under exposure of UV light for 24 hrs
[50].
2.3.3. Freeze-thaw cycles
The silicon molds containing homogenized DCM-PVA slurry (30:70,
50:50, 70:30 DCM to PVA) were frozen to −25 °C for 20 hrs and then
thawed at 30 °C for 4 hrs. This freeze-thaw cycles was repeated 30 other
times, and consequently lyophilized for 24 h [53].
2.3.4. Chamical crosslinking with genipin
2.3.4.1. PVA modification. PVA was modified with primary amine
functional groups (Scheme 1) via a method previously described [54].
Briefly, PVA was dissolved in MH2O at 90 °C to prepare a 12% wt/vol
solution. An equal volume of 10mol% 4-aminobutyraldehyde diethyl
acetal (4-ABA) (sigma) was calculated and added dropwise to the
solution. The pH was decreased close to zero by adding dropwise HCl
12M to the solution, and the solution was mixed for 1 h. Then, the pH
was increased to 8.0 with the addition of adequate amount of NH4OH.
The prepared solution was purified by dialysis tubing (MWCO 2000,
sigma) in deionized water and finally lyophilized. 1H nuclear magnetic
resonance spectroscopy (1H NMR) was used to confirm the modification
of the PVA by 4-ABA groups. For this issue, samples were dissolved in
D2O and the spectra was acquired using a Bruker 700 spectrometer
[54].
2.3.4.2. Genipin crosslinking. PVA and PVA-amine (PVA-A) were
dissolved in MH2O at 90 °C. Three different DCM-PVA slurry ratios
(30:70, 50:50, 70:30) were prepared similar to previous sections. Then,
adequate amount of genipin (Santacruz, sc-203057A) solution (0.04%
dry weight of genipin/dry weight of sample) in ethanol (10mg/ml) was
added to the slurry and homogenized again. Aliquots of homogenized
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slurry (250 µl) were placed in silicon molds and subsequently
crosslinked in shaker incubator at 37 °C for 3 days, then, frozen
overnight at −20 °C and for 1 h at −70 °C, and lyophilized for 24 hrs
[49]. Finally, 3 groups consisting of [genipin-crosslinked DCM-PVA-A
(30:70)] (GCDPA30), [genipin-crosslinked DCM-PVA-A (50:50)]
(GCDPA50), and [genipin-crosslinked DCM-PVA-A (70:30)]
(GCDPA70) scaffolds were prepared (Scheme 1).
2.4. Porosity measurement
The porosity of the scaffolds was determined using liquid dis-
placement via method previously described [49]. Briefly, a scaffold was
moved into a graduated cylindrical container that was filled with a
known volume of hexane (V1). The increasing of hexane volume as a
consequence of putting the scaffold in the container was measured as
(V2). The scaffold was removed after impregnation with hexane during
5min, and the remaining volume in the container was measured (V3).
The porosity percentage was calculated via the following formula:
porosity percentage=100× (V1−V3) / (V2− V3), where (V1− V3) is
the volume of pores in the scaffold, and (V2−V3) is the total volume of
the scaffold.
2.5. Water uptake and weight loss
The scaffolds (n= 3) were placed in PBS in a container at 37 °C and
95% humidity until the weight of the hydrated scaffolds stopped to
increase, by checking the weight of scaffolds at different times. Where
Wd is the weight of dried scaffold, and Wh is the weight of hydrated
scaffold, then the water uptake percentage was obtained via following
formula: 100× (Wh−Wd) /Wd. [55]. The weight loss of the constructs
at the end of each time point (a week) was determined using the
equation: 100× (Wi−Wf)/Wi, where (wi) is the initial weight of dry
sample and (wf) is weight of the final dry sample. The scaffolds washed
with deionized water to eliminate any PBS salt and weighed after va-
cuum drying at RT to calculate the percentage of the weight loss [56].
The average value of three samples was reported as the water uptake
and weight loss.
2.6. Crosslinking degree
Fourier transform infrared (FT-IR) spectroscopy was carried out to
determine the amount of crosslinking density [33]. FT-IR spectra of
NCDPA70 and GCDPA70 scaffolds were obtained using the FT-IR
spectrophotometer (Jasco 680 plus spectrometer, Japan). Cylindrical
KBr pellets were fabricated by mixing 1mg of the sample powder and
200mg of KBr salt [57]. The decrease in the absorbance peaks around
1600 cm−1 or around 800 cm−1 was employed to detect the presence of
amine groups in the NCDPA70 and GCDPA70 scaffolds to determine the
degree of crosslinking of the materials. [58]. These peaks were nor-
malized with the absorbance at 2931 cm−1 (CeH bond), which is un-
affected during formation of amide bonds. The inverse of the ratio of
(1600/2931 and 800/2931) were calculated to determine the amount
of crosslink density. The degree of crosslinking was defined as the
percentage of reacted amines after genipin reaction relative to the free
amines in the non-crosslinked scaffold [38,59].
Ninhydrin assay was also performed to determine the amount of
amine groups in the NCDPA70 and GCDPA70 samples to achieve
crosslink density of the scaffolds. The purple pigment produced after
the reaction of ninhydrin reagent (Sigma) with free amine groups in the
porous scaffolds was detected via a UV–Visible spectrophotometer at a
560 nm wavelength. The crosslinking density was calculated as the
percentage of reacted amines after crosslinking relative to the free
amines in the non-crosslinked scaffold [26].
2.7. Scanning electron microscopy
NCDPA70 and GCDPA70 scaffolds were sputter coated with gold.
The microstructure of the scaffolds was observed with scanning elec-
tron microscope (SEM, Zeiss, Germany). The pore sizes of scaffolds
were measured by drawing the boundary of the pores using Image J
software (Fiji-win 64). The area covering 15 pores was evaluated for
each scaffold [49].
2.8. Mechanical property of scaffolds
Young's modulus was measured via compression test using a me-
chanical testing machine (Santam, Iran) to explore the mechanical
properties of GCDPA70 hybrid scaffolds according to a method pre-
viously described [60]. The cylindrical scaffolds (n=3) with dimen-
sion 10× 3mm were compressed at a constant speed of 1.0mm/min.
The results from the stress–strain curves were used to determine the
Young's modulus of each sample.
2.9. Isolation and culture of ASCs
The ASCs were obtained from liposuction waste of subcutaneous
adipose tissue from the 4 female donors (Al Zahra Hospital, Isfahan
University of Medical Sciences) with age of 25–45 and an average
body–mass index of 25–30. The Institutional Ethics Committee of Iran
University of Medical Sciences approved informed consent and the
study. Collagenase type IA was used to digest adipose tissue at 37 °C for
30min according to previous work [61,62]. The cells were cultured on
75-cm2 culture flasks at a starting density of 6000 cells/cm2 in expan-
sion medium consisting of the Dulbecco’s modified Eagle’s medium
(DMEM, BI1025, Bioidea, Iran), 10% fetal bovine serum (FBS; Gibco-
10270), 1% penicillin-streptomycin (1025, Bioidea, Iran), and 10 ng/
mL basic fibroblast growth factor (b-FGF, RP-1112, Royan, Iran). The
cells were cultured at 37 °C in 5% CO2, and medium changed every
48 h. After reaching 90% confluence, the cells were harvested using
0.05% trypsin- EDTA (Bioidea, Iran) and counted to seed on the scaf-
folds [49,63,64].
2.10. Preparations of fibrin hydrogel
Human fresh-frozen plasma (FFP) and cryoprecipitate were ac-
quired from the Blood Donation Center (Isfahan, Iran) as starting ma-
terials. Thrombin solution was extracted by adding 400mM CaCl2 to
FFP (1:9 vol/vol), then the clots incubated in 37 °C for 90min, and
centrifuged at 2200 rpm at 4 °C for 10min to obtain thrombin con-
centrate. Following thawing, the cryoprecipitate was used as the fi-
brinogen component [61,65,66].
2.11. Proliferation, morphology and differentiation of ASCs on scaffolds
ASCs were resuspended in thrombin (cell density, 2× 107 cells/ml)
and seeded onto GCDPA70 scaffolds (1×106 cells/scaffold) by pipet-
ting. Cells were allowed to infiltrate and attach to the scaffolds for 1 h at
37 °C prior to the addition of fibrinogen to the scaffolds. Cell-scaffold
constructs were further incubated in the medium at 37 °C in an atmo-
sphere of 5% CO2 and 95% humidity and the medium changed every 48
hrs. Cell viability and proliferation within the scaffolds were analyzed
by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT, Sigma) assay at day 1, 3, and 7 of the culture according to
previous works [61].
Morphological characteristics and the distribution of the cells
within scaffolds were analyzed by SEM analysis. The cell seeded
[GCDPA70/ fibrin] hybrid constructs were washed with PBS and fixed
overnight in 3% glutaraldehyde at 4 °C. Different concentrations
ethanol was used to dehydrate the samples, then the samples were dried
and analyzed with a SEM [60,67].
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[GCDPA70/Fibrin] constructs were cultured for 14 and 28 days
(Table 1) in the 2ml of the culture medium (control medium, CRL)
composed of DMEM high-glucose (Bioidea BI1025), 1% penicillin–-
streptomycin (Bioidea-1025), L-ascorbic acid 2-phosphate (37.5mg/ml;
Sigma-A8960-5G), 1% ITS+Premix (Gibco-41400-45), and 10 nM
dexamethasone (Sigma-D4902-100MG) (Table 1). In addition, the
scaffolds were cultured for 14 and 28 days in the culture medium (TGF
medium) containing 10 ng/ml TGF-β3 (Sigma-T-9705) to investigate
chondrogenesis of the ASCs. The same volume of the cell/fibrin hy-
drogel seeded on the hybrid constructs were cultured in the well-known
micro-mass system (Table 1), in CRL and TGF medium to investigate
the chondroinductivity of the [GCDPA70/Fibrin] hybrid constructs
compared to the fibrin hydrogel [62]. The fibrin hydrogels and hybrid
constructs were subsequently cultured in the CO2 incubator at 37 °C,
the media changed every 2 days, and cultures were dismissed at day 14
and 28 for further evaluation [61,66,68].
2.12. Real-time polymerase chain reaction (RT-PCR)
Three fresh constructs were moved into 1.5 ml plastic vials and then
snap-frozen, crushed, and lysed using super RNA Extraction Kit for
Tissue and Cells (YT9080, YTA, Iran). Then, total RNA was extracted by
the purification system based on the manufacturer’s optional proce-
dure. After RNA extraction, the high-capacity cDNA Synthesis Kit
(YT4500, YTA, Iran) was used to synthesize single-stranded cDNA.
Real-time PCR Step One Plus real-time PCR system (Applied Biosystem)
with primers that were designed by Allele ID 7.6 software according to
our previous works, was used to compare the transcript levels for 3
different genes: aggrecan (ACAN, FWD: GTGGGACTGAAGTTCTTG,
REW: GTTGTCATGGTCTGAAGTT), types II collagen (COLIIA1, FWD:
CTGGTGATGATGGTGAAG, REV: CCTGGATAACCTCTGTGA) and types
X collagen: (COLX, FWD: AGAATCCATCTGAGAATATGC, REW: CCTC
TTACTGCTATACCTTTAC). Relative gene expression was measured
using 2X Real-Time PCR Master Mix, High ROX SYBR® Green1
(BioFACT). The glyceraldehyde 3-phosphate dehydrogenase (β-Actin,
FWD: GTTGTCGACGACGAGCG, REV: GCACAGAGCCTCGCCTT) primer
was considered as the internal control. Comparative Ct (ΔΔCt) was used
for calculation of the relative gene expression. [53,61]
2.13. Biochemical analysis
2.13.1. DNA quantification
Papain solution (1ml per each sample, 50 U/ml papain, in PBS pH
6, containing 5.5 mM EDTA and L-cysteine hydrochloride 125mM, all
materials from Sigma) were used to digest (n= 3 for each sample) at
65 °C for 24 h. The DNA quantitation kit, fluorescence assay (DNAQF
Sigma-Aldrich) containing Hoechst 33,258, calf thymus DNA standard,
and 10Χ Assay Buffer, was used to quantify DNA content of samples
according to the manufacturer’s instructions. Standard ascendant con-
centrations DNA of the calf thymus and papain digested samples in-
cluding lyophilized natural cartilage (CAR), devitalized costal cartilage
matrix (DCM), crosslinked cell free scaffold (CF) and cultured con-
structs in Day 1, 14, and 28 was quantified using a spectro-
fluorophotometer (BioTek FL600) at 360 nm excitation and 460 nm
emission. After drawing the standard curve, DNA concentration of each
unknown sample was obtained by interpolation of its absorbance from
the standard curve, and DNA content was reported in ng/mg of dry
weight of samples [50].
2.13.2. Sulphated glycosaminoglycans (GAG)s quantification
GAG content was measured by following the method previously
described on the papain digested samples [69,70]. Briefly, standard
ascendant concentrations of bovine chondroitin sulphate (Sigma) were
prepared. In a transparent 96-well plate, 250 µl 1,9-dimethylmethylene
blue solution (DMMB, Sigma) was added to each plate containing
standards and samples (40 µl), the plate was shacked for 2min before
reading absorbance by Spectrophotometric multi well plate reader
(Hyperion MPR4) at 540 nm. After the drawing standard curve, GAG
concentration of each unknown sample was obtained by interpolation
of its absorbance from the standard curve, and finally was reported in
weight of GAG/ weight of DNA (µg/mg) for each samples.
2.13.3. Collagen quantification
The hydroxyproline assay kit (MAK008 Sigma-Aldrich) was used to
quantify hydroxyproline content of samples according to the manu-
facturers’ instructions. 100 µl HCl 12M (sigma) were used to digest
10mg of lyophilized samples (n= 3 for each group) at 120 °C for 3 h
[69,71]. 0, 2, 4, 6, 8, and 10 µl of the 0.1 mg/mL hydroxyproline
standard solution was added into a 96 well plate. In addition, 10 µl of
each digested unknown samples were transferred to a well. All wells
consisting of standards and unknown samples were evaporated and
dried. 100 µl of the Chloramine T/Oxidation buffer mixture were added
to each wells. The plate was incubated at room temperature for 5min.
100 µl of the diluted DMAB reagent were added to each well, and in-
cubated for 90min at 60 °C. Finally, the absorbance was measured by
spectrophotometric multi well plate reader (Hyperion MPR4) at
540 nm. After drawing the standard curve, hydroxyproline concentra-
tion of each unknown sample was obtained by interpolation of its ab-
sorbance from the standard curve. Finally, hydroxyproline contents
were reported in mg hydroxyproline per 10mg of samples.
2.14. Histological analyses
Constructs were fixed 24 h at 4 °C in 10% buffered formalin in PBS
solution. Constructs were processed by increasing ethanol solutions
before cleared by xylene series. Then, the samples were embedded in
paraffin and cut into 5 μm slices. Xylene-cleared sections were stained
using general histological staining, Hematoxylin and Eosin (H&E). For
staining of GAGs, Toluidine blue staining (0.125%, 20 sec) was per-
formed, and also xylene-cleared sections were treated with hematoxylin
for 5min, 0.02% fast green for 1min, 1% aqueous safranin-O solution
for 30min, rinsed with distilled water, and dehydrated and cleared and
mounted on microscope slides [49,67].
Immunohistochemical staining was also performed on 5-µm sections
using monoclonal antibodies to type II collagen (ab3092; Abcam). For
antigen retrieval the slides incubated in hyaluronidase 8mg/ml (Sigma)
for 3 h at 37 °C. The nonspecific binding sites were blocked using
blocking buffer and slides were incubated with primary antibodies at
4 °C over-night. Then, after washing, slides were labeled with secondary
antibody (anti-mouse IgG, ab2891; Abcam) conjugated with horse-
radish peroxidase and then established using 3,3′- diaminobenzene
substrate (DAB kit, ab94656; Abcam). The cell free scaffold was
Table 1
The composition and abbreviation of the different culture groups in the current study.
Group Composition Time (day) Abbreviation
Fibrin/Micro-mass culture cell+ fibrin+ control medium 28 F-28
Fibrin-TGF-β3/Micro-mass culture cell+ fibrin+TGF-β3 medium 28 F-TGF-28
Cell free [GCDPA70/ fibrin] scaffold+ control medium 14,28 CF-14, CF-28
[GCDPA70/ fibrin] cells+ scaffold+ control medium 14, 28 CRL-14, CRL-28
[GCDPA70/ fibrin]-TGF-β3 cells+ scaffold+TGF-β3 medium 14, 28 TGF-14, TGF-28
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considered as proper positive controls for antibody to confirm antibody
specificity [50,61].
2.15. Statistical analysis
For the statistical analysis, data were evaluated using the
Kolmogorov-Simonov test for normal distribution analysis of variables
and (one-way analysis of variance) post-hoc test was employed to de-
termine significance between different groups and different time points
(α=0.05) of the MTT, ELISA and RT-PCR results.
3. Results
3.1. PVA amination
The 1H NMR spectrum for aminated PVA is shown in Fig. 1-I. PVA
was modified with 10% target amination. Peaks at chemical shifts of
3 ppm confirmed successful amination. The efficiency (36%) and ami-
nation percentage (4.25% per hydroxyl groups of polymer chains) was
calculated from the ratio of amine peak to the eCH peak in the spectra.
3.2. Scaffolds fabrication
The results of solubility test (Table 2) showed that the scaffolds
cross-linked via freeze-thaw cycles, UV irradiation, dehydrothermal
treatment, also using 0.04% (wt/wt) genipin were soluble in PBS. These
methods were not efficient enough to crosslink PVA and DCM to make
stable structures. Otherwise, amine modification of the PVA increased
polymer reactivity, and PVA-A and DCM crosslinked efficiently (Fig. 1-
II) after 72 h at 37 °C, while crosslinking of unmodified PVA and DCM
was not efficient at the same condition. The results of the gross mor-
phology (Fig. 1- III) and porosity measurement (Table 2) showed sig-
nificant shrinkage and decrease in the porosity of the GCDPA30 and
GCDPA50 scaffolds composed of 30% and 50% DCM respectively,
compared to the GCDPA70 scaffolds composed of 70% (wt/wt) DCM
(Fig. 1-III). Therefore, GCDPA70 scaffolds were chosen as the appro-
priate scaffolds for following characterizations and cell studies, while
GCDPA30 and GCDPA50 were excluded from the study.
3.3. Water uptake
It is necessary to highlight the effect of DCM on the degradation
performance of the hybrid scaffolds, as biodegradation is a critical
Fig. 1. I: 1H NMR spectrum of aminated PVA, Successful backbone modification was verified by amine peak at 3 ppm. II: Genipin crosslinking of PVA and PVA-A with
DCM; (A): DCM/PVA wasn’t able to crosslink in combination with 0.04% ganipin, while (B): DCM/PVA-A crosslinked easily in the same condition. III: Volume change
of (A): genipin-crosslinked and (B): non-crosslinked DCM/PVA-A scaffolds. Gross photographs of left to right: 30%, 50%, and 70% DCM containing scaffolds.
Table 2
The results of solubility, porosity, and appearance of the cross-linked scaffolds via freeze-thaw cycles, UV irradiation, dehydrothermal treatment, and using 0.04%
(wt/wt) genipin. The solubility test showed that PVA-A and DCM crosslinked efficiently after 72 h at 37 °C, while crosslinking of unmodified PVA and DCM was not
efficient at the same condition using 0.04% (wt/wt) genipin (n= 3).
Crosslinking method DCM content (%) Color and appearance Dissolution time (hrs) Porosity%
Non crosslinked scaffolds 30 white- rectangular 2 82 ± 2.5
50 white- rectangular 2 87 ± 2.1
70 white- rectangular 2 92 ± 3
Freeze-thaw cycles 30 white- shrunk 24 –
50 white- shrunk 24 –
70 white- shrunk 24 –
Dehydrothermal treatment 30 white- rectangular 72 81 ± 4.5
50 white- rectangular 72 85 ± 3.2
70 white- rectangular 72 93 ± 5.1
UV- irradiation 30 yellowish- rectangular 24 –
50 yellowish- rectangular 24 –
70 yellowish- rectangular 24 –
Genipin-crosslinked DCM/PVA 30 Pale blue-rectangular 48 –
50 Pale blue-rectangular 48 –
70 Pale blue-rectangular 48 –
Genipin-crosslinked DCM/PVA-A 30 dark blue- shrunk insoluble 45 ± 6
50 dark blue- shrunk insoluble 71 ± 5.1
70 dark blue- rectangular insoluble 89 ± 3
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factor to evaluate the regeneration of the injured cartilage. Hence,
water uptake is principally considered as an important factor for the
degradation of the scaffold. Water uptake and biodegradation tests
carried out just for GCDPA70 scaffolds, since other scaffolds were ex-
cluded from the study as earlier explained. The results of water uptake
test showed that the water absorption capacity of the GCDPA70 scaf-
folds was 504 ± 26.7% (n= 3). Therefore, the construct can absorb
culture medium and support proper nutrient infiltration. The weight
loss for the GCDPA70 scaffolds after incubation in PBS is shown in
Fig. 2. The results showed that the weight loss of the scaffolds was
gradual during the degradation period. After a week of incubation, the
scaffolds lost about 6.1 ± 0.65% of its initial weight, followed by a
gentle weight loss during the remaining weeks. As a result,
20.99 ± 0.44% of the original weight was lost after 10 weeks of in-
cubation.
3.4. Crosslinking degree
FT-IR spectroscopy carried out just for GCDPA70 scaffolds and other
scaffolds were excluded from the study. The crosslink density of the
GCDPA70 scaffold was calculated from FT-IR spectrum and is shown in
Fig. 3. The calculated crosslinking density was 50.7 ± 15.5% (n=3).
Also, ninhydrin assay results indicated that the crosslinking degree of
genipin crosslinked scaffolds was up to 63.19 ± 9.9% (n=3).
3.5. Scanning electron microscopic
The SEM micrographs of the NCDPA70 (Fig. 4-A) and GCDPA70
scaffolds (Fig. 4-B) showed pore size between 37 and 122 and
22–95 µm, and the average pore diameter was 67 ± 22 and
57 ± 21 µm, respectively. The macroporous structure with inter-
connected and well-arranged pores was generated within the scaffold.
After 24 h of culture, SEM analyses showed that ASCs attached effi-
ciently on the (GCDPA70/fibrin) hybrid constructs and started to se-
creted ECM (Fig. 4-C).
3.6. Mechanical properties
The results of the Force–Extension curve of the GCDPA70 constructs
were demonstrated that elastic modulus of the scaffolds and elongation
at break have been found to be 14.7 ± 2.7 kPa and 62.39 ± 6.56%
respectively (n=3).
3.7. MTT assay
The results of MTT assay at days 1, 3 and 7 showed the viability of
the ASCs in the (GCDPA70/Fibrin) hybrid constructs compared to 2D
culture as the control (Fig. 5). The analysis showed a significant pro-
liferation of ASCs on the developed scaffolds at day 3 and day 7
Fig. 2. Weight loss% vs. incubation time in PBS for GCDPA70 scaffolds.
Fig. 3. FT-IR spectrums of the A: NCDPA70 and B: GCDPA70 to evaluate crosslink density of the scaffold. The decrease in the absorbance peaks around a: 800 cm−1
or b:1600 cm−1 was employed to detect the presence of amine groups. These peaks were normalized with the absorbance at c: 2931 cm−1 (CeH bond) which is
unaffected during formation of amide bonds (n=3).
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compared to day 1. Yet, ASCs metabolic activity in 2D cell cultures was
approximately 2 times higher than in (GCDPA70/Fibrin) constructs.
3.8. Gene expression
The two chondrogenesis gene markers, ACAN, COLIIA1, and the
hypertrophic gene marker COLX were analyzed in control, and TGF
groups for [GCDPA70/Fibrin] constructs at day 14 and 28, and fibrin
hydrogel cultured in micro mass system at day 28 (Fig. 6). In control
medium, the two positive chondrogenic markers were significantly
upregulated by the hybrid scaffolds. COLIIA1 was significantly in-
creased relative to day 1, which exhibited approximately 12-fold
through day 14. A 60-fold increase was also observed until day 28.
ACAN transcript values were also significantly upregulated 3-fold over
the first 14 days, to 6-fold by day 28. Also, a significant upregulation of
COLX was observed. By day 14, COLX levels had increased approxi-
mately 6.6-fold relative to day 1. A slight trend showing an increase in
COLX production was noted through day 28, which showed 8.8-fold
upregulation. In TGF medium, the two positive chondrogenic markers
were significantly upregulated by the fibrin hydrogel. COLIIA1 was
significantly increased relative to day 1, which exhibited approximately
618-fold through day 28. ACAN transcript values were also significantly
upregulated 94-fold over the 28 days of culture. Also, a significant
upregulation of COLX was observed. By day 28, COLX levels had
increased approximately 68-fold relative to day 1.
3.9. Quantification of DNA and GAGs
A significant decrease in DNA content (weight of DNA/dry weight of
sample) among the lyophilized cartilage (CAR), devitalized cartilage
matrix, (DCM), and genipin crosslinked cell free scaffold (CF)
(6.99 ± 0.075, 5.72 ± 0.10, and 3.77 ± 0.043 µg/mg respectively)
was measured. There was a significant decrease in DNA content be-
tween CF scaffolds at day 1 and day 14 (3.77 ± 0.043,
2.51 ± 0.36 µg/mg respectively). However, no significant difference in
DNA content between CF scaffolds at day 14 and 28 (2.51 ± 0.36,
2.47 ± 0.35 µg/mg respectively) was observed. At day 14, there was
significant difference in DNA content across medium types in the hybrid
scaffolds. The hybrid scaffold group demonstrated an upregulation in
DNA content (1.72 ± 0.011 µg/mg) in response to TGF-β3 supple-
mentation compared to the respective control group
(0.83 ± 0.024 µg). At day 28, also TGF-β3 treated scaffolds had sig-
nificantly higher DNA content (1.83 ± 0.263 µg/mg) than control
group (1.04 ± 0.264 µg/mg) (Fig. 7A).
There was no significant difference in GAG content (weight of GAG/
weight of DNA) between lyophilized cartilage and DCM, but significant
decrease was observed after genipin crosslinking of the scaffolds
(78.83 ± 3.82, 66.96 ± 5.79, and 52.78 ± 0.01 µg/mg respectively).
Fig. 4. Scanning electron micrographs of A: NCDPA70, B: GCDPA70scaffolds, and C: cell seeded [GCDPA70/Fibrin] hybrid constructs (scale bars a, b, c= 100 and A,
B, C=50 µm).
Fig. 5. Comparison of MTT assay results to show viability of ASCs in the (GCDPA70/Fibrin) hybrid constructs in compare with 2D culture plates, used as a control.
(Data presented as mean ± SD, *p < 0.05 comparing to day 1; n=3).
M. Setayeshmehr, et al. European Polymer Journal 118 (2019) 528–541
535
There was a significant decrease in GAG content among the CF scaffolds
at day 1, 14 and 28 (52.78 ± 0.01, 46.92 ± 7.82, and
39.87 ± 6.18 µg/mg respectively). Difference in GAG content among
the medium types in the hybrid scaffolds was also observed. The day 14
GAG data displayed a significant increase in GAG content in the hybrid
scaffold group in response to TGF-β3 supplementation
(54.46 ± 6.24 µg/mg) compared to the control scaffold
(38.98 ± 8.82 µg/mg). At day 28, also TGF-β3 treated scaffolds had
significantly higher GAG content (63.00 ± 15.07 µg/mg) than the
control group (57.00 ± 11.15 µg/mg) (Fig. 7B).
There was a significant decrease in collagen content (weight of
hydroxylproline per 10mg of sample) between lyophilized cartilage
and DCM, and also a significant decrease was observed after genipin
crosslinking of the scaffolds (0.162 ± 0.002, 0.158 ± 0.002,
0.128 ± 0.001mg respectively). At day 1, 14, and 28, no decrease was
observed in collagen content between the CF scaffolds (0.128 ± 0.001,
0.124 ± 0.001, 0.120 ± 0.003mg respectively). The hybrid scaffolds
exhibited a significant increase in collagen content in the presence of
TGF-β3 compared to their respective control constructs. Also, at day 14
and 28, TGF-β3 treated scaffolds had significantly higher collagen
content (0.049 ± 0.003, and 0.056 ± 0.003mg respectively) than
control groups (0.004 ± 0.003, and 0.01 ± 0.001mg respectively)
(Fig. 7C).
3.10. Histology
Histology of cell-free scaffolds stained via H&E, toluidine blue,
Safranin-O/fast green staining exposed unfilled matrices with big pores.
Failure of the pores did not occur in the scaffolds during culture. The
cartilage matrix alone stained positively for all staining methods
(Fig. 8). In control medium, after 28 day of culture the fibrin hydrogel
established minimal matrix production, while hybrid scaffolds ex-
hibited robust newly synthesized matrix that stained positive for GAGs
(Fig. 8). In fibrin and hybrid constructs, supplementation with TGF-β3
significantly improved the synthesis of new matrix that stained strongly
for GAGs, while fibrin hydrogel in micro-mass system exhibited most
synthesized matrix compared to hybrid scaffolds. In the hybrid con-
structs, new matrix deposition was non-uniform and localized to some
parts of the scaffolds (Fig. 8). The scaffolds had a higher cell density on
the side in which the cells were pipette (Fig. 8).
4. Discussion
According to previous studies, synthetic polymers such as PLGA,
PLA, PCL, PVA-MA, and PEG have been more frequently used in hybrid
scaffolds fabrication. These polymers are biodegradable, biocompatible
and their rate of biodegradation can be controlled by the degree of
polymerisation, crosslinking, or hybridization with other synthetic and
natural biomaterials. To overcome the disadvantage of synthetic poly-
mers, such as their complications in facilitating cell nutrient transfer,
hydrophobicity, lack of cell recognition signals and functional adhesion
sites, and induction of inflammatory responses, these materials are
often modified before cell culture. Therefore, hybrid scaffolds con-
taining both synthetic polymers and ECM derivatives can be considered
as a proper strategy for TE applications [6].
The findings of this study demonstrated that only genepin was able
to cross-link these two synthetic (PVA) and natural (DCM) components
of the scaffolds, among the crosslinking methods that were tested. A
novel amine modification approach was performed to enhance cross-
linking reactivity of PVA. Genepin crosslinking could prevent cell-
mediated contraction in the hybrid constructs; a critical characteristic
of scaffolds that is essential to maintain for in vivo and in vitro TE ap-
plications. Genepin crosslinking produced scaffolds able to support cell
attachment and chondrogenic induction of ASCs.
After 28-days of culture, genepin crosslinked scaffolds retained their
original shape, while fibrin hydrogels showed contraction throughout in
vitro culture. In chondrogenic medium without exogenous growth fac-
tors, RT-PCR results combined with histological assessments showed
Fig. 6. Expression of cartilaginous transcripts for [(GCDPA70/fibrin) hybrid constructs in day 14 and 28 in control medium (CRL-14, CRL-28), and in the presence of
the TGF-β3 (TGF-14, TGF-28), and fibrin hydrogel in day 28 in control medium (F-28), and in the presence of the TGF-β3 (F-TGF-28). Relative quantification of
COLIIA1, ACAN, and COLX gene expression normalized to day one transcript values exposed upregulation of the genes. (Data presented as mean ± SD; *p < 0.05
compared to day 1; #p < 0.05 between the indicated data; n=3).
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that during chondrogenic differentiation ASCs synthesized a greater
amount of cartilaginous matrix in hybrid scaffolds compared to fibrin
hydrogel. In previous studies, many ECM derivatives have been used as
scaffolds for TE applications [26,27,49,50]. Other researchers showed
that CDM from articular cartilage as a porous scaffold could in part
induce chondrogenic differentiation of ASCs without exogenous GFs,
showing minimum ECM synthesis from seeded bone marrow derived
mesenchymal stem cells (MSC)s [50]. In the present study, human
costal cartilage was investigated for its potential chondroinduction
ability. In addition, PVA was used as a synthetic biocompatible polymer
to conjugate DCM obtained from costal cartilage, to increase bio-
mechanical properties.
In this study, physical crosslinking methods including freeze-thaw
cycles, DHT, and UV exposure were performed to conjugate PVA and
DCM, but solubility tests showed that none of these methods weren’t
efficient to crosslink the scaffolds. In a previous study, a PVA solution
(16 wt%, Mw 146,000–186,000) hydrogel combined with articular
cartilage derived matrix was crosslinked via freeze-thaw cycles to fab-
ricate porous scaffolds. The goal of this study was to combine PVA
mechanical strength with ECM biological features [72]. The difference
with our results could be due to the difference in Mw and concentration
of the used polymers. Also, DHT by heating scaffolds in a dry en-
vironment at 120 °C for 24 hrs, and UV light exposure at an energy
concentration of 8 J/cm2 from a 254 nm source for 80min (UV) [50]
was performed to crosslink CDM scaffolds. Nevertheless, these methods
weren’t efficient to crosslink DCM/PVA composite scaffolds in-
vestigated in the present study.
(PVA)-chondroitin sulfate (CS) hydrogels were also studied after
being crosslinked using glutaraldehyde. CS contained in the scaffolds
enhanced Baby hamster kidney (BHK) cell growth and attachment be-
tween cells and hydrogels. Moreover, the strength of PVA provided
scaffolds with mechanical properties proper to use as a material in TE
[55]. In present study, an adequate amount of the genipin solution was
added to the DCM/PVA slurry directly, to crosslink the materials and
form a hydrogel. The solubility results demonstrated that 0.04% wt/wt
genipin was not efficient to crosslink DCM/PVA mixture, while amine-
modified PVA crosslinked perfectly in a similar condition. In a previous
study, scaffolds composed of cartilage powder were incubated in dif-
ferent genipin solutions to fabricate CDM scaffolds, and a 0.05% gen-
ipin solution supported ASCs proliferation and differentiation, and also
prevented cell-mediated scaffold contraction [49].
Between three different (DCM/PVA-A) compositions, (70:30) mix-
ture showed minimum shrinkage and maximum porosity percentage
similar to non-crosslinked scaffolds, so we considered this ratio as the
best composition for further characterization and cell studies. The
average pore diameter of the non-crosslinked and genipin-crosslinked
scaffolds was 67 ± 22 and 57 ± 21 µm, respectively, and the porosity
was 89 ± 3%. According to a previous work, CDM scaffolds cross-
linked with high concentration of genipin had similar pore size and
porosity to the non-crosslinked scaffolds (174.9 ± 5.3 µm), while
scaffolds treated by lower concentration showed significant reduction
in pore size (107.0 ± 3.6 µm). Also, the porosities were between
94.7% and 95.9% [49]. Another research group fabricated macro-
porous PVA scaffolds with an average pore diameter of 15.7 μm, a pore
size range 8–304 μm, and apparent porosity 81 ± 5% [73]. Moreover,
Stecco et al. fabricated PVA and (PVA/Articular cartilage derived ma-
trix (ACDM)) scaffolds, which presented a rather homogenous porous
structure with a pore size ranging from 4 to 10 μm [72]. In the present
Fig. 7. A: DNA content; B: GAG content; and C: Collagen content of lyophilized cartilage (CAR), devitalized cartilage matrix (DCM), and GCDPA70 cell free scaffold
(CF), (GCDPA70/fibrin) hybrid constructs in control medium (CRL), and (GCDPA70/fibrin) hybrid constructs in the presence of TGF-β3 (TGF) after 14, and 28 days
of culture. All constructs demonstrated increased cellular proliferation, GAG, and collagen contents in the presence of TGF-β3 after 14, and 28 days of culture. (Data
presented as mean ± SD; *p < 0.05 comparing to the CF scaffolds data of the same day, **p < 0.05 comparing to the CRL-14 group, #p < 0.05 between the
indicated data; n= 3).
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study, the average pore size was smaller compared to the CDM scaffolds
investigated by Cheng et al. [49]; while the fabricated GCDPA70
composite scaffolds exhibited a significant bigger pore size than PVA
scaffolds reviewed in the previous studies [73]. Scaffolds’ pore size and
shape play a key role in chondrogenic differentiation, and can partly
account for the differential activities of ASCs in the scaffolds
[49,74,75]. However, the incorporation of the DCM particles in PVA
network using amine modification and consequently genipin cross-
linking could modulate pore size and shape compared to PVA and PVA/
ACDM scaffolds investigated in previous studies.
The biomechanical behavior of tissue-engineered constructs is a
critical outcome for functional TE [76]. The findings of a previous study
on ASC-seeded CDM constructs suggested it is likely that the engineered
tissue will need to be reinforced to attain functional biomechanical
Fig. 8. Chondrogenesis in fibrin/micro-mass culture and hybrid scaffolds. Cartilaginous constructs formed by ASCs cultured under control and TGF mediums.
Hematoxylin and eosin (A, B, C, D, E), Toluidine blue (F, G, H, I, J), Safranin-O/fast green (K, L, M, N, O) staining, and Immunoreactivity for COLII (P, Q, R, S, T) after
28 days culture. General morphology, demonstrating a central core surrounded by a basophil transition zoon staining with H&E, metachromatic staining with TB, and
red staining with Safranin-Oe are typical of cartilage phenotype. The cell free constructs showed porous structures after culture period. After 28-day culture,
abundant synthesized neomatrix was observed in the groups of the fibrin and hybrid constructs in the present of TGF-β3. Hybrid construct presented more cartilage
like neomatrix compared to the fibrin hydrogel in control medium (scale bar= 125 µm). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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properties [77], while the value of elastic modulus of healthy articular
cartilage reported in previous studies is in the range from 130 to
573 kPa [78–80]. In the present study, compressive tests demonstrated
that reinforcement of the DCM with PVA-A and crosslinking by genipin
(0.04%) exhibited a compression modulus of the hybrid construct to
14.7 ± 2.2 kPa. Compressive aggregate modulus of the genipin cross-
linked CDM scaffolds investigated in a previous study were ranged from
55 and 89 kPa [49]. Moreover, the results of the unconfined compres-
sive testing found that 10% wt PVA scaffolds possessed a Young’s
modulus of 15.09 ± 1.97 kPa at 30% strain [53]. The resulted
GCDPA70 constructs showed very close value of elastic modulus com-
pared to the scaffolds based on PVA and CDM.
The results of the MTT assay showed an increase in cell viability at
days 3 and 7 compared to day 1, which suggested that GCDPA70
scaffolds were cell compatible after cross-linking, consistent with pre-
vious reports. Previous studies have reported very low cytotoxicity of
genipin. Furthermore, ASCs seeded on the genipin-crosslinked CDM
scaffolds showed comparable proliferative capability with respect to the
non-crosslinked CDM scaffolds [49].
In the present study, gene transcript levels on day 28 for ACAN,
COLII A1, and COLX, were upregulated in fibrin hydrogels and genipin-
crosslinked hybrid scaffolds in both CRL and TGF groups compared to
ASCs at day 1. Significant upregulation of COLIIA1 in the fibrin-TGF
group compared to scaffold-TGF group was also observed. Reversely, in
CRL medium, the gene transcript levels of COLIIA1 in the scaffold-CRL
group compared to fibrin-CRL group showed significant upregulation.
The observed results suggested that the DCM did not lose its chondro-
genic potential after crosslinking with genipin, and provide support for
the chondroinduction ability of the hybrid scaffolds. On the other hand,
the remaining endogenous active biomolecules in the scaffolds might
also effect the chondrogenic differentiation of the ASCs. Similar to what
observed in our study, Cheng et al. reported that ACAN and COLII A1
gene transcript levels were significantly upregulated on day 14 in
genipin-crosslinked CDM scaffolds for MSCs [49].
Histological and immunohistochemical sections in all TGF-β3
treated samples showed the expression of both GAGs and COLII mac-
romolecules. The ASCs-fibrin micro-mass hydrogels appeared more
homogenously and uniformly stained for GAGs and COLII compared to
hybrid constructs. Similarly, Cheng et al. showed that GAGs and COLII
appeared more homogeneous in the non-crosslinked compared to gen-
ipin-treated CDM groups [49]. Fibrin hydrogels treated with TGF-β3
showed a higher synthesis of both GAGs and COLII matrices compared
to hybrid scaffolds. However, it is essential to mention that, the TGF-β3
treated ASC-fibrin group produced a hypertrophic phenotype as shown
by COLX gene upregulation and according to histological staining
(Fig. 8), while COLII dominated the composition. Since ASC-seeded
hybrid scaffolds treated by TGF-β3 induced synthesis of the COLII and
minimized a hypertrophic phenotype, ASCs responded to signals gen-
erated from the DCM to differentiate towards a more hyaline chon-
drocyte phenotype. Proper stimuli to induce rapid tissue remodeling is
necessary to induce collagen biosynthesis [81]. As observed in this
study, via proper ASCs stimulation from the hybrid scaffolds and TGF-
β3, COLII biosynthesis was significantly induced in a 28-days culture
period.
At day 14 and 28, TGF-β3 treated scaffolds had significantly higher
DNA content than the control medium (Fig. 7) that was according to the
results of a previous study performed by Rowland et al. [50]. At day 28,
CRL group demonstrated an upregulation in DNA content (Fig. 7).
Rowland et al. showed that the CDM scaffolds fabricated via physical
crosslinking methods in the presence of TGF-β3 exhibited a significant
decrease in GAG content, because of GAG release from the scaffolds in
the culture medium [50]. In our study, at day 14 cell free scaffolds
showed no significant difference in GAG content, but at day 28 there
was a significant decrease in GAG content across the medium (Fig. 7),
which could have happened due to the scaffold biodegradation. The
hybrid constructs treated with TGF-β3 had a higher GAG content
compared to CRL medium samples (Fig. 7). Similarly, the results of the
previous work of Cheng et al. showed that genipin-crosslinked CDM
exhibited a significant increases in normalized GAG content at day 28
[49]. Rowland et al. also observed that the non-crosslinked CDM scaf-
folds exhibited a significant decrease in collagen content compared to
crosslinked constructs across the different culture media [50]. In the
present study, at day 14 and 28 cell free crosslinked scaffolds showed
no difference in COL content across the medium, consistent with pre-
vious reports. The hybrid constructs treated with TGF-β3 presented
higher COL content compared to CRL medium samples at days 14 and
28 (Fig. 7).
Contraction of scaffolds in vivo can generate a gap among the en-
gineered construct and the native surrounding tissue, and could result
in the dislodgement of the implanted construct. A recent study showed
that the properties of genipin-crosslinked chitosan/COL scaffolds could
be greatly affected by various genipin concentrations [82]. In addition,
Cheng et al. showed that non-crosslinked CDM scaffolds showed sig-
nificant construct contraction, while increasing genipin concentration
resulted in almost no volume decrease over 28 days’ culture period
[49]. In addition, the influence of crosslinking on contraction of the
scaffold and chondrogenesis in a COLII–GAG scaffolds was explored by
Vickers et al. [27]. However, they found that chondrogenicity was in-
versely related to the crosslinking density of the COLII–GAG scaffolds.
Their hypothesis was that prevention of cell-mediated contraction
might have eventually restricted chondrogenesis in the scaffolds [27].
Reversely, Cheng et al. showed that CDM scaffolds with 50% cross-
linking density successfully permitted ASCs proliferation and chon-
drogenesis similar to the non-crosslinked CDM. They elaborated that
the endogenous factors and biomolecules could distinguish CDM nat-
ural scaffolds from COLII–GAG synthetic scaffolds investigated in the
Vickers study [27,49]. However, in the present study, fabricated hybrid
scaffolds represented completely different behaviors in CRL and TGF
medium compared to fibrin hydrogel in the micro-mass culture system.
The results of the RT-PCR and histology demonstrated that the fibrin-
TGF group showed higher synthesis of both GAGs and COLII matrices
compared to the hybrid scaffolds, which was according to the results of
the study performed by Vickers et al. [27]. In the CRL medium, results
confirmed the significant upregulation of COLII and GAG in the hybrid
scaffolds compared to the fibrin hydrogel, which was according to the
results of the study performed by Cheng et al. [49]
As the histological images showed, the distribution of the cells
within the scaffolds was not uniform as well as in fibrin hydrogels. The
use of bioreactors for cell seeding may prove useful in this system to
increase uniformity in tissue-engineered constructs, and consequently
enhance cell growth and differentiation in GCDPA70scaffolds.
Previous studies have used allogenic costal cartilage to regenerate
cartilaginous tissue damages including primary and revision rhino-
plasty, orbital floor defects, and microtia by surgical reconstruction. To
reduce the risk of disease transmission, gamma (γ) irradiation of allo-
genic cartilage was used without further treatments [22,23]. Moreover,
chemical crosslinking of xenogeneic or allogeneic ECM scaffolds may
elicit an undesired immunogenic response [83]. Therefore, additional in
vivo evaluation is necessary to fully recognize the clinical implication of
our observations in the present study.
5. Conclusions
Generally, beneficial effects of using devitalized cartilage matrix as
the constructive material for scaffold fabrication is preservation of the
GFs and ability of chondroinduction in the ASCs. The results highlight
the importance of the amine-modification of the PVA on crosslinking of
the DCM-PVA and reduction of the crosslinker percentage and conse-
quently, minimum contraction and reduction in pore size of the scaffold
and improvement of cell-matrix interactions and chondrogenic differ-
entiation of ASCs in scaffolds. Taking into reason the RT-PCR, bio-
chemical, and histological results together, showed that scaffolds
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composed of DCM is able to stimulate ASCs chondrogenesis and also
DCM can significantly influence ASC responses to TGF-β3 and produced
the most required products in terms of increased cellular proliferation,
expression of chondrogenic genes, enhanced GAG and collagen synth-
esis, and reduction of hypertrophic phenotypes compared to fibrin
hydrogel. The amine modification of the PVA and consequent cross-
linking via genipin could potentially arise from increase mechanical
properties, reduction scaffold contraction, which offers bigger pore size
suitable for cell proliferation and conservation of cell-matrix interac-
tions in addition to matrix synthesis, that mediate chondrogenic dif-
ferentiation. Future studies are required to improve cell distribution
within the scaffold, and to enhance mechanical properties of the scaf-
folds and to elucidate specific cell-matrix interactions responsible for
mediating chondrogenesis in ASCs.
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